KAM
JNP
Krensavage Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-308,478
| Closed | -$2.68M | – | 15 |
|
|
2018
Q2 | $2.68M | Sell |
308,478
-24,360
| -7% | -$212K | 0.69% | 13 |
|
|
2018
Q1 | $3.38M | Sell |
332,838
-107,264
| -24% | -$1.09M | 0.82% | 14 |
|
|
2017
Q4 | $2.13M | Buy |
440,102
+196,974
| +81% | +$955K | 0.67% | 14 |
|
|
2017
Q3 | $1.11M | Hold |
243,128
| – | – | 0.34% | 14 |
|
|
2017
Q2 | $1.23M | Hold |
243,128
| – | – | 0.37% | 15 |
|
|
2017
Q1 | $1.16M | Sell |
243,128
-47,725
| -16% | -$227K | 0.37% | 15 |
|
|
2016
Q4 | $1.63M | Buy |
290,853
+2,559
| +0.9% | +$14.3K | 0.58% | 16 |
|
|
2016
Q3 | $1.6M | Buy |
288,294
+539
| +0.2% | +$2.99K | 0.58% | 17 |
|
|
2016
Q2 | $2.02M | Buy |
287,755
+788
| +0.3% | +$5.52K | 0.73% | 20 |
|
|
2016
Q1 | $1.9M | Sell |
286,967
-1,359
| -0.5% | -$8.98K | 0.68% | 21 |
|
|
2015
Q4 | $2.97M | Buy |
288,326
+8,609
| +3% | +$88.7K | 0.95% | 20 |
|
|
2015
Q3 | $3.3M | Sell |
279,717
-47,900
| -15% | -$564K | 1.19% | 20 |
|
|
2015
Q2 | $3M | Buy |
327,617
+11,468
| +4% | +$105K | 1.13% | 20 |
|
|
2015
Q1 | $1.96M | Hold |
316,149
| – | – | 0.89% | 21 |
|
|
2014
Q4 | $1.77M | Buy |
+316,149
| New | +$1.77M | 0.99% | 22 |
|